Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P01178 (oxytocin)
 15,767 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

An 18-year-old primipara developed acute hypertension leading to cerebral edema and convulsions following the IV injection of a bolus of 10 units of oxytocin with 0.2 mg methylergonovine maleate. Oxytocin in a dose of more than 2 units should not be administered IV in a single injection, as severe hypotension may result. If oxytocin is required, it can be injected either IM, or by IV pump or drip. The use of ergot in obstetrics should be limited to the treatment of life-threatening postpartum hemorrhage and be given only by the IM route. Ergot should not be administered to patients with cardiac, renal, or hypertensive disease, or in association with a vasoconstrictor.
 ...
PMID:Postpartum hypertension and convulsion after oxytocic drugs. 103 98

A study is made of the contractile and bioelectrical activities of the uterine muscle of guinea-pig in vitro and of rabbit in vitro and in situ, as well as their Oxytocin-induced changes upon different balance of the ovarial hormones. In rabbits in situ the uterine muscle contractions are longer and are recorded with a slower rhythm than in vitro. Both in situ and in vitro the sensitivity of the myometrium to Oxytocin is lower upon domination of progesteron and higher upon domination of oestrogen. In guinea pigs the myometrium is least sensitive to Oxytocin in the juvenile animals as compared with the sexually mature ones. The sensitivity of the guinea-pig myometrium to oxytocin in the various phases of the oestral cycle is weakest during dioestrus and strongest during oestrus.
 ...
PMID:Variations in the spontaneous activity of the uterine muscle in vitro and in situ and its response to oxytocin. 103 28

Since March 1972 we have been applying Prostaglandin F2 alpha in 6 patients between the 8th and 12th week of pregnancy, in 2 patients between the 13th and 16th week, in 16 patients from the 17th week onwards, and in 10 women at term. The intravenous and extraamniotic application of Prostaglandin for interruption of pregnancy has proved a success even in severe general diseases. No severe side effects have been observed. Antidotes are beta-sympathicomimetics as for Oxytocin, too Prostaglandin is a valuable pharmacon in the obstetrical area.
 ...
PMID:[Prostaglandin F2alpha as a method of choice for interruption of pregnancy (author's transl)]. 105 6

The enzymic inactivation of oxytocin by liver, kidney, uterus and pancreas homogenate subcellular fractions of hens was studied. Oxytocin was most rapidly degraded by the soluble fraction of tissues examined. All the subcellular fractions of liver and kidney inactivated oxytocin, but only the microsomal and soluble fractions of uterus and pancreas showed the oxytocin-inactivating activity. The location of enzymes inactivating oxytocin in subcellular fractions of hen tissues was investigated with the aid of synthetic analogues of oxytocin (deamino-oxytocin and deamino-carba1-oxytocin). The carboxamidopeptidase activity, hydrolyzing the amide bonds in the linear portion of oxytocin was located in the soluble fraction of hen liver, kidney and uterus. No carboxamidopeptidase activity in the pancreatic soluble fraction was found. These results showed that aminopeptidase activity is bound to heavy subcellular particles in the hen tissue. An action of unknown endopeptidases was observed in the microsomal fraction of uterus and pancreas.
 ...
PMID:Inactivation of Oxytocin and its analogues by subcellular fractions of hen tissues. 108 26

A clinical experiment was undertaken to assess the usefulness of PG(prostaglandin)E2 in priming cervixes with unfavorable Bishop scores prior to induction of term delivery. The study, which used 30 pregnant woman at term, was a double-blind study employing placebo or .5 mg PGE2 tablets in a dosage schedule of 2 tablets at 3-hourly intervals for 3 doses. During the priming, vital signs, fetal heart rate, and uterine contractility were monitored. Between 8-12 hours following the last dose of medication or placebo, intravenous oxytocin infusion was begin for labor induction. Oxytocin infusion failed to induce labor in 3 of the primed and 4 of the unprimed patients. Fetal heart rates were altered in 1 baby from each group; otherwise, all babies in both groups did well. There was no difference between the 2 groups as to the dosage of oxytocin required to induce active labor or to effect delivery. The duration of oxytocin stimulation and the interval from onset of priming to delivery were also comparable in the 2 groups. The study results show that PGE2 does not have appreciable priming benefits when unfavorable prelabor pelvic conditions prevail.
 ...
PMID:Preinduction priming with oral prostaglandin E2. 109 9

Blood oxytocin was determined on 10 Holstein cows during normal milking and during milking when epinephrine was injected intravenously before or after udder stimulation. The average peak oxytocin concentration during normal milking was 399.7 muU/ml plasma and was reached at 1 min after teat cup application. Oxytocin concentration in blood plasma declined rapidly after peak concentration and dropped to 30.5 muU/ml plasma within 4 min after the start of milking. By 5 min after removal of the teat cups, it had declined to less than 4 muU/ml plasma. The administration of epinephrine, either before or after udder washing, inhibited milk ejection as indicated by milk production and oxytocin concentrations. Peak oxytocin concentrations were 1.05 muU/ml plasma 1 min after teat cup application when epinephrine was injected before udder washing and 8.6 muU/ml plasma at teat cup application when epinephrine was injected after udder washing. These results and the use of a beta receptor blocker to inhibit the effect of epinephrine at the myoepithelial cell level indicated that epinephrine inhibited release of oxytocin from the neurohypophysis.
 ...
PMID:Epinephrine inhibiting milk ejection in lactating cows. 111 75

Stimulation of uterine activity after amniotomy has been carried out with prostaglandin E2 (PGE2) tablets in two dosage regimens and with intravenous oxytocin. Oxytocin stimulation was the most successful. The difference in success rate was most marked in nulliparous patients and those with low Bishop score.
 ...
PMID:Prostaglandin E2 tablets compared with intravenous oxytocin in induction of labour. 112 Feb 20

Oxytocin administered intravenously to the anaesthetized rat produced dilatation of the blood vessels of the cremaster muscle at concentrations ranging from 2.5 times 10-minus 11 to 2.5 times 10-minus 9 M. When applied topically to the exposed vessels it produced constriction at concentrations ranging from 2.5 times 10-minus 12 to 5.0 times 10-minus 8 M. Oxytocin was thus similar to adrenaline in eliciting opposite effects when applied to the serosa or to the intima of skeletal muscle blood vessels.
 ...
PMID:The effect of oxytocin on blood vessels of cremaster muscle of the rat. 112 87

The purpose of this work was to investigate the effect of oxytocin on prostaglandin F (PGF) concentrations in uterine venous effluent. PGF was measured in utero-ovarian venous plasma from three pregnant ewes and in posterior vena caval plasma from two puerperal ewes, during oxytocin administration. Oxytocin caused 4.9 - 5.3-fold increases in PGF concentrations in the pregnant animals, the response increasing towards term. In the puerperal animals oxytocin caused 3.7 - 17.2-fold increases in PGF concentrations with a marked latency in the response. Measurement of uterine activity and progesterone and total unconjugated oestrogen concentrations indicated that neither uterine contractions nor a decreased uterine blood flow accounted for the elevated PGF levels stimulated by oxytocin.
 ...
PMID:Stimulation by oxytocin of prostaglandin f levels in uterine venous effluent in pregnant and puerperal sheep. 113 26

Pharmacological and biochemical properties were investigated on deamino-dicarba-[Gly-7]-oxytocin (Y-5350). This is a newly developed compound, in which the disulfide bond and [Pro-7] of deamino-oxytocin are substituted by an ethylene linkage and glycine respectively. Bioassayed Y-5350 exhibited 202.6 u/mg of oxytocic activity, 4.6 u/mg of avian depressor activity, 441.2 u/mg of rat milk-ejecting activity and 0.02 u/mg of rat antidiuretic activity, however, adepressor activity was also evident in rats. In particular, the diuration of antidiuretic activity was short. Moreover, the oxytocic activity in pregnant rats and rabbits was weak in comparison with oxytocin. Cumulative dose-response studies were carried out on the isolated rat uterus using van Dyke-Hasting solution. The intrinsic activity was the same level as that of oxytocin, and the pD2 value was 8.62. Oxytocic activity was much enhanced by the existence of 0.5 or 2mM magnesium ion in vitro. However, the agreement between in vivo and in vitro oxytocic activity was not complete when assay was carried out in the prescence of 2 mM magnesium ion. Oxytocin was inactivated by the serum of pregnant women. In the experiment using rats, oxytocin was also destroyed by the extracts of uterus, kidney and liver. In contrast, Y-5350 was not destroyed by any of the enzyme solutions mentioned above.
 ...
PMID:Studies on pharmacological and biochemical properties of deamino-dicarba-[GLY-7]-oxytocin (Y-5350). 115 7


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>